Cargando…
Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection
OBJECTIVE: To investigate the regulation mechanism of T cell immunoglobulin and mucin domain-3 (Tim-3) combined with toll-like receptor 3 (TLR3) or TLR4 on antiviral immune and inflammatory response in patients with chronic hepatitis C virus (HCV) infection. METHODS: Patients with chronic HCV infect...
Autores principales: | Nan, Yue-min, Su, Shan-shan, Niu, Xue-min, Zhao, Su-xian, Zhang, Yu-guo, Wang, Rong-qi, Kong, Ling-bo, He, Huan, Zheng, Huan-wei, Sun, Dian-xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536634/ https://www.ncbi.nlm.nih.gov/pubmed/27329385 http://dx.doi.org/10.1177/0300060516647548 |
Ejemplares similares
-
Regulatory Phenotype, PD-1 and TLR3 Expression in T Cells and Monocytes from HCV Patients Undergoing Antiviral Therapy: A Randomized Clinical Trial
por: Su, Shan-shan, et al.
Publicado: (2014) -
Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection
por: Zhang, Ying, et al.
Publicado: (2011) -
Suppression of Allograft Rejection by Tim-1-Fc through Cross-Linking with a Novel Tim-1 Binding Partner on T Cells
por: Xiao, Liang, et al.
Publicado: (2011) -
Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity
por: Dou, Shuaijie, et al.
Publicado: (2021) -
Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)